ADMA Biologics Faces Investor Fraud Lawsuit

ADMA Biologics is in hot water, folks. A lawsuit claims the company pulled a fast one on investors by not disclosing a sketchy transaction and inflating revenue figures. As a result, when the truth hit the fan, shareholders were left holding the bag with significant financial losses. What does it mean for you? If you bought ADMA shares during the specified period and lost money, you might want to check if you can get involved in the lawsuit. It could be a chance to recover some of your losses—because who doesn’t love a little justice served with a side of cash?